Trial Outcomes & Findings for Study Evaluating OsseoSpeed™ Narrow Implant in the Upper and Lower Anterior Jaw (NCT NCT00646113)

NCT ID: NCT00646113

Last Updated: 2019-11-18

Results Overview

Overall implant survival rate evaluated clinically and radiographically

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

72 participants

Primary outcome timeframe

Evaluated at implant placement and at the 5 years follow-up after implant placement

Results posted on

2019-11-18

Participant Flow

Unit of analysis: Implants

Participant milestones

Participant milestones
Measure
OsseoSpeed™ TX 3.0
OsseoSpeed™ TX 3.0 mm diameter implants (lengths 11 mm, 13 mm and 15 mm).
Overall Study
STARTED
69 97
Overall Study
COMPLETED
61 86
Overall Study
NOT COMPLETED
8 11

Reasons for withdrawal

Reasons for withdrawal
Measure
OsseoSpeed™ TX 3.0
OsseoSpeed™ TX 3.0 mm diameter implants (lengths 11 mm, 13 mm and 15 mm).
Overall Study
Lost to Follow-up
5
Overall Study
Adverse Event
3

Baseline Characteristics

Study Evaluating OsseoSpeed™ Narrow Implant in the Upper and Lower Anterior Jaw

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
OsseoSpeed™ TX 3.0S
n=97 Implants
OsseoSpeed™ TX 3.0 mm diameter
Age, Continuous
32.5 years
STANDARD_DEVIATION 15.11 • n=5 Participants
Sex: Female, Male
Female
33 Participants
n=5 Participants
Sex: Female, Male
Male
36 Participants
n=5 Participants
Region of Enrollment
Sweden
15 participants
n=5 Participants
Region of Enrollment
Denmark
14 participants
n=5 Participants
Region of Enrollment
United Kingdom
12 participants
n=5 Participants
Region of Enrollment
Italy
10 participants
n=5 Participants
Region of Enrollment
Germany
4 participants
n=5 Participants
Region of Enrollment
Spain
14 participants
n=5 Participants

PRIMARY outcome

Timeframe: Evaluated at implant placement and at the 5 years follow-up after implant placement

Population: A total of 69 subjects were enrolled in the study and received a total of 97 implants.

Overall implant survival rate evaluated clinically and radiographically

Outcome measures

Outcome measures
Measure
OsseoSpeed™
n=97 Implants
OsseoSpeed™ TX 3.0 mm diameter
Implant Survival Rate
93 Implants

Adverse Events

OsseoSpeed™ TX 3.0S

Serious events: 0 serious events
Other events: 39 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
OsseoSpeed™ TX 3.0S
n=69 participants at risk
OsseoSpeed™ TX 3.0 mm diameter
Product Issues
Crown loss
14.5%
10/69 • Number of events 10 • 5 years
Product Issues
Abutment fractures
10.1%
7/69 • Number of events 7 • 5 years
Product Issues
Implant lost
5.8%
4/69 • Number of events 4 • 5 years
Infections and infestations
Common cold
20.3%
14/69 • Number of events 30 • 5 years
General disorders
Headache
5.8%
4/69 • Number of events 8 • 5 years

Additional Information

Manager Global Clinical Research

Dentsply Sirona Implants, Mölndal, SWEDEN

Phone: 0046313763500

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60